DataMeds AI, Inc. Common Stock
MEDS
5 hedge funds and large institutions have $1.53M invested in DataMeds AI, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$743K |
| 2 |
HF
HRT Financial
New York
|
+$262K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$101K |
| 4 |
VFIC
Valley Forge Investment Consultants
Audubon,
Pennsylvania
|
+$77.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.95K |
Top Sellers
MEDS Hedge Fund Activity: Q1 2025 in Review
5 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in DataMeds AI, Inc. Common Stock (MEDS) for Q1 2025, worth a combined $1.53M.
Buyers outnumbered sellers: 5 funds opened new MEDS positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $743K.
- 5 institutional investors held DataMeds AI, Inc. Common Stock (MEDS) as of Q1 2025, up from 0 in Q4 2024.
- Funds reported $1.53M of DataMeds AI, Inc. Common Stock stock for Q1 2025.
- 5 funds opened new DataMeds AI, Inc. Common Stock positions in Q1 2025 and 0 closed out, a net change of +5 holders.
- The largest DataMeds AI, Inc. Common Stock buyer in Q1 2025 was Millennium Management, an estimated $743K added.
Based on aggregated 13F filings for Q1 2025.